Autoimmune Diseases: all 672 studies
Page 1 of 7. Open to participants first (272), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye DiseaseRecruitingNCT07885605Phase 1
- A Study of BMS-986553 in Participants With Refractory Autoimmune DiseasesNot yet recruitingNCT07873931Phase 1
- First in Human Study of ALT-01 in Healthy ParticipantsNot yet recruitingNCT07865442Phase 1
- Exploratory Study of the Efficacy of HuMoSCs (Human Monocyte-derived Suppressor Cells) on Glandular Involvement in Sjögren's SyndromeNot yet recruitingNCT07861828Not applicable
- C-CAR168, an Autologous Anti-CD20/BCMA Chimeric Antigen Receptor T-Cell Therapy, in Participants With Systemic Sclerosis (SSc) Refractory to Standard TherapyNot yet recruitingNCT07854483Phase 1
- Incidence and Predictors of Early Clinical Relapse Within Six Months After Thymectomy in Patients With Myasthenia GravisNot yet recruitingNCT07853378
- Glycemic Control and Quality of Life Evolution for Patients With T1D Using the myLoop Powered by CamAPS FX System in Combination With FreeStyle Libre 3 / 3 Plus Sensors in FranceNot yet recruitingNCT07835685
- Capillary Sampling in Clinical Populations Undergoing MonitoringNot yet recruitingNCT07802665
- Study to Evaluate the Safety and Preliminary Efficacy of CD19 CAR-T Cell Therapy (TranspoCART19) in Patients With Refractory Lupus NephritisRecruitingNCT07799116Phase 1/2
- Inflammation, Autoimmunity and Healthy Ageing in Menopause Transition. An Observational, Cross-sectional StudyNot yet recruitingNCT07784400
- Study of PTC844 in Participants With Active Rheumatoid ArthritisNot yet recruitingNCT07779616Phase 2
- A Study to Test CRT-402 in Refractory Autoimmune DiseaseRecruitingNCT07778446Phase 1/2
- Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility StudyRecruitingNCT07759115Not applicable
- A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHANot yet recruitingNCT07738822Phase 1/2
- Sociocognitive Intervention and Rehabilitation Program in Multiple SclerosisNot yet recruitingNCT07734675Not applicable
- A Study of ATG-201 in Adult Participants With Autoimmune DiseasesNot yet recruitingNCT07732309Phase 1
- The Effect of Nicorandil on Rheumatoid Arthritis PatientsRecruitingNCT07730723Phase 2/3
- C-CAR168, an Autologous Anti-CD20/BCMA Chimeric Antigen Receptor T-Cell Therapy, in Participants With Lupus Nephritis Refractory to Standard TherapyNot yet recruitingNCT07729826Phase 2
- METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)RecruitingNCT07699380Phase 2
- Hyaluronidase for Sclerodactyly in Systemic Sclerosis TrialNot yet recruitingNCT07697274Early Phase 1
- Study Evaluating a Gene Therapy for IPEX Syndrome Through the Expression of FOXP3 on Deficient T Cells to Produce Tregs-like.Not yet recruitingNCT07697118Phase 1/2
- Targeting GLUT1 to Control Autoimmunity in Type 1 DiabetesNot yet recruitingNCT07695727
- Evaluation of Safety and Efficacy of Autologous LB-DTK-CMV in Patients With Antiviral-Resistant and Refractory Cytomegalovirus Retinitis.RecruitingNCT07679412Not applicable
- RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune DiseasesNot yet recruitingNCT07674147Early Phase 1
- CD19-Directed CAR-T Cell Therapy in Refractory Systemic Lupus ErythematosusNot yet recruitingNCT07659704Phase 1/2
- Early Clinical Study on the Safety, Tolerability, Pharmacokinetics, and Efficacy of STR-P005Not yet recruitingNCT07655453Not applicable
- Tissue Modeling in Systemic Sclerosis Using Induced Pluripotent Stem Cells (iPSCs)Not yet recruitingNCT07650565Not applicable
- A Trial in Healthy Adult Participants and Adults With Autoimmune Disease to Test How HBM7020 is Tolerated and Absorbed in the BodyRecruitingNCT07649265Phase 1
- The Italian Multiple Sclerosis and Related Disorders RegisterEnrolling by invitationNCT07636876
- Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of Arnovie101, an mRNA-LNP-Based In Vivo CAR-T Therapy, for the Treatment of B Cell-Mediated Autoimmune Diseases (SLE and AIHA)RecruitingNCT07629596Early Phase 1
- Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom BurdenRecruitingNCT07621809Phase 3
- SHIELD-T1D: Shingrix and GLP-1 Agonist for Beta-Cell Preservation in Recent-Onset Type 1 Diabetes.Not yet recruitingNCT07614412Phase 2
- Safety and Efficacy of KSVCBD Injection in Autoimmune DiseasesNot yet recruitingNCT07613411Early Phase 1
- Early Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of STR-P005Not yet recruitingNCT07605637Not applicable
- CD19/BCMA UCAR-T for B Cell-Related Autoimmune DiseaseRecruitingNCT07586267Early Phase 1
- A Study Investigating Intravenous Human Normal Immune Globulin 10% in Adults With Stiff Person SyndromeNot yet recruitingNCT07552987Phase 3
- A Study of JADE101 in Participants With Immunoglobulin A NephropathyRecruitingNCT07541287Phase 2
- Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid ArthritisRecruitingNCT07524244Not applicable
- Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune DiseasesNot yet recruitingNCT07523282Phase 1
- Pharmacokinetics, Efficacy and Safety of Olokizumab In Patients With Juvenile Idiopathic ArthritisRecruitingNCT07517575Phase 2
- Immun4Cure Cohort of Autoimmune DiseasesRecruitingNCT07515638
- Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)RecruitingNCT07513181Phase 2
- Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune DiseaseRecruitingNCT07507201Early Phase 1
- Standardized Italian netwoRk Enrolling iNdividuals With Islet-AutoantibodiesNot yet recruitingNCT07503366
- The T1DWATCH Study: a Screening for Type 1 Diabetes Autoantibodies in Children for Early Detection and Intervention.Not yet recruitingNCT07492550
- A Clinical Study of the Safety, Tolerability and Preliminary Efficacy of CD19/BCMA-targeted CAR-T Therapy in Refractory Autoimmune DiseasesRecruitingNCT07490951Not applicable
- Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune DiseasesRecruitingNCT07470151Not applicable
- Study of S-4321 in Participants With an Autoimmune or Immune-mediated DiseaseRecruitingNCT07455578Phase 1
- CD19 CAR T-Cell Therapy for Refractory Systemic Lupus ErythematosusRecruitingNCT07432334Phase 1
- Central Vein Sign in Multiple Sclerosis Extension StudyRecruitingNCT07424027Not applicable
- Clinical Study of AFN50 Injection in the Autoimmune DiseasesRecruitingNCT07408336Early Phase 1
- Statin and Vitamin D Treatment in Patients With Thyroid Eye DiseaseRecruitingNCT07400757Not applicable
- Integrating Vaccination Into Hospital Care Pathways for Vulnerable PatientsNot yet recruitingNCT07391046
- Exploratory Study on LNP-mRNA Drugs Targeting CD19/BCMA for the Treatment of Relapsed and Refractory Autoimmune DiseasesNot yet recruitingNCT07388212Early Phase 1
- A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults.RecruitingNCT07366866Phase 1
- To Evaluate the Safety and Tolerability of STR-P004 for the Treatment of Immune-mediated Kidney DiseasesNot yet recruitingNCT07363954Not applicable
- Exploratory Study on mRNA Therapy Targeting CD19 for the Treatment of Refractory Autoimmune DiseasesNot yet recruitingNCT07362758Early Phase 1
- Single-cell Immune Response to Controlled Gluten Ingestion in Pediatric Celiac DiseaseRecruitingNCT07362654Not applicable
- Exploratory Study on the Treatment of Relapsed and Refractory Immune Related Diseases With WGb-0301 InjectionNot yet recruitingNCT07349823Early Phase 1
- The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 DiabetesRecruitingNCT07348432
- Familial Systemic SclerodermaRecruitingNCT07343115
- A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus NephritisRecruitingNCT07328581Phase 2
- Safety and Efficacy Study of RXIM002 in Severe, Relapsed or Refractory Autoimmune DiseasesRecruitingNCT07322718Early Phase 1
- CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune DiseaseRecruitingNCT07305116Phase 1
- A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune DiseasesRecruitingNCT07284797Phase 1
- Exploratory Clinical Study of Second-generation CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in Treating Paediatric B Cell-related Autoimmune DiseasesRecruitingNCT07283315Early Phase 1
- Ferroptosis Role in the Pathophysiology of Systemic Lupus ErythematosusRecruitingNCT07260942Not applicable
- Safety and Immunogenicity of PCV20 in Pediatric Patients With Autoimmune Rheumatic DiseasesRecruitingNCT07252791Phase 4
- Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune DiseasesRecruitingNCT07246096Early Phase 1
- Electromagnetic Immunotherapy Mapping and Cytokine Forecasting Study (QSIT)Enrolling by invitationNCT07221565Phase 1/2
- Retrospective Epidemiological Study of Patients in the National Cohort of the French TMA CenterRecruitingNCT07205861
- CAR-T in Subjects With Relapsed/Refractory Autoimmune DiseaseRecruitingNCT07193667Not applicable
- Mass Spectrometry-based Immune Profiling in Autoimmune DiseasesEnrolling by invitationNCT07188285
- PS-002 for the Treatment of IgA Nephropathy in AdultsRecruitingNCT07182227Phase 1/2
- LUpus Eritematoso Sistemico NETwork and RegistryNot yet recruitingNCT07175610
- An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune DiseasesRecruitingNCT07174843Early Phase 1
- A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid ArthritisRecruitingNCT07171983Phase 1
- Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune DiseasesNot yet recruitingNCT07161193Phase 1/2
- Inectolizumab With Steroid Optimization in Newly Treated NMOSDNot yet recruitingNCT07159893Not applicable
- Exploratory Clinical Study on the Safety of STR-P004RecruitingNCT07143617Not applicable
- A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune DiseasesRecruitingNCT07123519Phase 1
- GT719 Injection for Moderate to Severe Refractory Autoimmune DiseasesRecruitingNCT07122076Early Phase 1
- Anti CD19/BCMA CAR Gene Therapy for Autoimmune DiseasesRecruitingNCT07121777Not applicable
- A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune DiseasesRecruitingNCT07115745Phase 1
- RN1201 Injection for Autoimmune Diseases Refractory to Standard TherapiesRecruitingNCT07105735Phase 1
- A Clinical Study of YTS109 Cell for R/R Autoimmune DiseasesRecruitingNCT07104721Phase 1
- Ublituximab in Autoantibody Positive Immune Mediated Necrotizing MyopathyRecruitingNCT07103746Phase 2
- A Study of LUCAR-DKS1 in Subjects With Relapsed/Refractory Autoimmune DiseasesRecruitingNCT07095075Early Phase 1
- A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune DiseaseRecruitingNCT07085104Phase 1
- CAR-T Therapy for Refractory Autoimmune DiseasesRecruitingNCT07059169Not applicable
- A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)RecruitingNCT07059000Phase 3
- CAR-T Cells Therapy for Patients With Autoimmune DiseasesRecruitingNCT07052565Not applicable
- A Study of CAR-T Cells in Subjects With Autoimmune DiseasesNot yet recruitingNCT07040917Early Phase 1
- Natural History of Type 1 Interferonopathies: Insights From a European CohortRecruitingNCT07040774
- Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia GravisRecruitingNCT07039916Phase 3
- Autoimmune Endocrine Disease Related Antibodies Before the Start of Immune Checkpoint Inhibitor TherapyRecruitingNCT06993727Not applicable
- Atacicept in Multiple Glomerular DiseasesRecruitingNCT06983028Phase 2
- Study of BHV-1300 in Graves' DiseaseRecruitingNCT06980649Phase 1
- A Study of OL-108 in Relapsed/Refractory Autoimmune DiseasesRecruitingNCT06980597Phase 1
- UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune DiseasesNot yet recruitingNCT06978738Phase 1